title: Diagnostic value of bronchoalveolar lavage in peripheral lung cancer.
abstract: A prospective study has been performed to assess the value of the addition of bronchoalveolar lavage (BAL) to the routine bronchoscopic exploration with bronchial washing (BW) and postbronchoscopy sputum (PBS) procedures in the diagnosis of peripheral primary lung cancer not visible through bronchoscope when fluoroscopic guidance is not available. BW, BAL, and PBS were performed in 67 patients with suspected primary lung cancer by peripheral lung lesion on chest radiograph (39 nodules and 28 infiltrates) and nonendoscopically visible lesion. The sequence of procedures was in all cases BW, BAL, and post-bronchoalveolar lavage bronchoaspirate (PBBA). An attempt was made to collect early morning postbronchoscopy samples of sputum (PBS) on 3 consecutive days. BW and PBBA were collected in the same test tube, and the cytologic result was considered as BW diagnostic yield. If there were negative bronchoscopic results, either percutaneous fine-needle aspiration or open-lung biopsy were performed for diagnosis. Fifty-five patients were found to have malignant disease (23 adenocarcinomas, 22 squamous cell carcinomas, six small cell carcinomas, and four bronchioloalveolar cell carcinomas). BAL was positive in 18 of the 55 (33%) carcinomas, and it gave the only positive result in six (11%). BW was also positive in 18 of the 55 (33%), but it gave positive results in only 3 (5%). PBS was positive in 13 of the 43 (30%) patients from whom samples could be spontaneously obtained and were suitable for cytologic examination (not consisting of saliva), and gave the only positive result in three (7%).(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Servei de Pneumologia, Hospital General, Universitari Vall d'Hebron, Barcelona, Spain.
authors.forename: J
authors.initials: J
authors.lastname: de Gracia
authors.forename: C
authors.initials: C
authors.lastname: Bravo
authors.forename: M
authors.initials: M
authors.lastname: Miravitlles
authors.forename: N
authors.initials: N
authors.lastname: Tallada
authors.forename: R
authors.initials: R
authors.lastname: Orriols
authors.forename: J
authors.initials: J
authors.lastname: Bellmunt
authors.forename: M
authors.initials: M
authors.lastname: Vendrell
authors.forename: F
authors.initials: F
authors.lastname: Morell
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001706:Biopsy / Q000706:statistics & numerical data; D001992:Bronchoalveolar Lavage Fluid / Q000166:cytology* / Q000382:microbiology; D001999:Bronchoscopy / Q000379:methods / Q000706:statistics & numerical data; D016009:Chi-Square Distribution; D003581:Cytodiagnosis / Q000706:statistics & numerical data; D005069:Evaluation Studies as Topic; D005260:Female; D005336:Fiber Optic Technology; D006801:Humans; D008168:Lung / Q000000981:diagnostic imaging / Q000473:pathology; D008175:Lung Neoplasms / Q000175:diagnosis* / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D011859:Radiography; D012680:Sensitivity and Specificity; D013183:Sputum / Q000382:microbiology